Search results for "OUTCOME"

showing 10 items of 5148 documents

Efficacy of 3 toothbrush treatments on plaque removal in orthodontic patients assessed with digital plaque imaging: a randomized controlled trial.

2013

Good oral hygiene is a challenge for orthodontic patients because food readily becomes trapped around the brackets and under the archwires, and appliances are an obstruction to mechanical brushing. The purpose of this study was to compare plaque removal efficacy of 3 toothbrush treatments in orthodontic subjects.This was a replicate-use, single-brushing, 3-treatment, examiner-blind, randomized, 6-period crossover study with washout periods of approximately 24 hours between visits. Forty-six adolescent and young adult patients with fixed orthodontics from a university clinic in Germany were randomized, based on computer-generated randomization, to 1 of 3 treatments: (1) oscillating-rotating …

AdultMaleToothbrushingRandomizationAdolescentPlaque removalElectrical Equipment and SuppliesDental PlaqueDentistryOrthodonticsManual toothbrushlaw.inventionYoung AdultRandomized controlled trialOrthodontic ApplianceslawImage Processing Computer-AssistedMedicineHumansSingle-Blind MethodChildFluorescent DyesOrthodonticsCross-Over Studiesbusiness.industryBrushEquipment DesignCrossover studyTreatment OutcomePhotography DentalPlaque imagingFemaleFluoresceinToothbrushbusinessAmerican journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics
researchProduct

Effectiveness of a miswak extract-containing toothpaste on gingival inflammation: a randomized clinical trial.

2015

Objectives In this study, the efficacy of a miswak extract-containing toothpaste (Salvadora persica) on gingival inflammation was compared with that of a herbal and a conventional toothpaste. Methods Non-smoking outpatients with sulcus bleeding index (SBI) ≥25% and with periodontal pocket depths ≤3 mm were randomly selected and divided into three groups: M-group, miswak extract-containing toothpaste; P-group, herbal toothpaste; and C-group, conventional toothpaste. After instructing the patients to brush their teeth twice a day for 3 weeks with the assigned toothpaste using a flat-trimmed manual toothbrush, a thorough oral examination was performed by a calibrated examiner (EH). The primary…

AdultMaleToothbrushingbusiness.product_categoryMiswakGingival and periodontal pocketDentistryOral hygienelaw.invention03 medical and health sciencesGingivitis0302 clinical medicineRandomized controlled trialSalvadora persicalawmedicineHumansDentistry (miscellaneous)Prospective StudiesProspective cohort studyAgedToothpastebiologybusiness.industryPlant ExtractsSalvadoraceae030206 dentistryMiddle Agedbiology.organism_classificationGingivitisTreatment Outcome030220 oncology & carcinogenesisPatient ComplianceFemalemedicine.symptombusinessToothpastesInternational journal of dental hygiene
researchProduct

Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell–depleted reduced-intensity transplantation

2006

AbstractAllogeneic hematopoietic stem cell transplantation (SCT) regimens incorporating the lymphocytotoxic CD52 antibody alemtuzumab demonstrate efficient engraftment and reduced graft-versus-host disease (GVHD). However, these protocols substantially impair posttransplantation antiviral and antitumor immunity. To accelerate immune reconstitution after alemtuzumab-based reduced-intensity SCT, we administered prophylactic CD8-depleted donor lymphocyte infusions (DLIs) starting on days 60 and 120 after transplantation. DLIs were processed in an immunomagnetic good manufacturing practice depletion procedure resulting in a 2.5- to 6-log reduction in CD8 T cells. Of 23 high-risk patients with h…

AdultMaleTransplantation ConditioningCD52Antibodies Neoplasmmedicine.medical_treatmentT cellImmunologyGraft vs Host DiseaseHematopoietic stem cell transplantationCD8-Positive T-LymphocytesAntibodies Monoclonal HumanizedImmunotherapy AdoptiveBiochemistryLymphocyte DepletionHLA AntigensmedicineHumansCytotoxic T cellAlemtuzumabPeripheral Blood Stem Cell TransplantationImmunomagnetic Separationbusiness.industryGraft SurvivalAntibodies MonoclonalCell BiologyHematologyMiddle AgedDonor Lymphocytesmedicine.diseaseTransplantationTreatment Outcomesurgical procedures operativeGraft-versus-host diseasemedicine.anatomical_structureHematologic NeoplasmsLangerhans CellsImmunologyAlemtuzumabFemaleK562 CellsbusinessFollow-Up Studiesmedicine.drugBlood
researchProduct

The influence of university students stress mindsets on health and performance outcomes

2018

Background Emerging evidence indicates that holding particular stress mindsets has favorable implications for peoples’ health and performance under stress. Purpose The aim of the current study was to examine the processes by which implicit and explicit stress mindsets relate to health- and performance-related outcomes. Specifically, we propose a stress beliefs model in which somatic responses to stress and coping behaviors mediate the effect of stress mindsets on outcomes. Methods Undergraduate university students (N = 218, n = 144 females) aged 17– 25 years completed measures of stress mindset, physical and psychological wellbeing, perceived stress, perceived somatic responses to stress, p…

AdultMaleUniversitiesAdolescentHealth Statusperformance outcomesPsyArXiv|Social and Behavioral Sciences|Health Psychology|StressPsyArXiv|Social and Behavioral Sciences|Health Psychology|PreventionPersonal SatisfactionMindsetsStressSocial and Behavioral SciencesMedical and Health SciencesPsyArXiv|Social and Behavioral Sciences|Health Psychology|Mental HealthajattelutavatEducationYoung AdultPsyArXiv|Social and Behavioral Sciences|Health PsychologyAcademic PerformanceHumansPsychologyAdaptationPsyArXiv|Social and Behavioral Sciences|Health Psychology|IllnessStudentssuorituskykyHealth PsychologyopiskelijatPsychology and Cognitive SciencesPerceived controlstressiPsyArXiv|Social and Behavioral Sciences|Health Psychology|Health-related BehaviorFOS: PsychologyPsyArXiv|Social and Behavioral Sciences|Health Psychology|Social healthPsyArXiv|Social and Behavioral Sciencesbepress|Social and Behavioral Sciences|Psychology|Health PsychologyQuality of Lifebepress|Social and Behavioral SciencesPsychologicalFemalePublic HealthCopingPsyArXiv|Social and Behavioral Sciences|Health Psychology|TreatmentterveysImplicit beliefs
researchProduct

The effect of vibration therapy on neck myofascial trigger points: A randomized controlled pilot study

2020

[EN] Background: The purpose of this study was to evaluate the effect of low-frequency self-administered vibration therapy into myofascial trigger points in the upper trapezius and levator scapulae on patients with chronic non-specific neck pain. Methods: Twenty-eight patients with chronic non-specific neck pain were randomly assigned into a vibration group, receiving 10 self-applied sessions of vibration therapy in the upper trapezius and levator scapulae trigger points; or a control group, receiving no intervention. Self-reported neck pain and disability (Neck Disability Index) and pressure pain threshold were assessed at baseline and after the first, fifth and 10th treatment sessions. Fi…

AdultMaleUpper trapeziusmedicine.medical_specialtyPressure painmedicine.medical_treatmentESTADISTICA E INVESTIGACION OPERATIVABiophysicsPilot ProjectsVibration03 medical and health sciences0302 clinical medicineNeck painThreshold of painmedicineHumansDisabled PersonsOrthopedics and Sports MedicineIn patientPROYECTOS DE INGENIERIAPhysical Therapy ModalitiesNeck painNeck PainRehabilitationTrigger pointsbusiness.industryRehabilitationTrigger Points030229 sport sciencesMiddle AgedTreatment periodTreatment OutcomePain thresholdPhysical therapyFemalemedicine.symptombusiness030217 neurology & neurosurgeryNeck Disability IndexClinical Biomechanics
researchProduct

Urological dysfunctions in patients with Parkinson’s disease: clues from clinical and non-invasive urological assessment

2018

Abstract Background Autonomic nervous system dysfunction, common in patients with Parkinson’s disease (PD), causes significant morbidity and it is correlated with poor quality of life. To assess frequency of urinary symptoms in patients with PD, without conditions known to interfere with urinary function. Methods Non-demented PD patients were consecutively enrolled from the outpatients clinic of our department. Scales investigating motor and non-motor symptoms were carried out. Evaluation of urinary dysfunctions was carried out using the AUTonomic Scale for Outcomes in Parkinson’s disease (SCOPA-AUT) questionnaire. Patients underwent noninvasive urological studies (nUS), including uroflowme…

AdultMaleUrologic Diseasesmedicine.medical_specialtyNeurologyParkinson's diseaseUrinary systemAutonomic dysfunction030232 urology & nephrologyNon-motor symptomsUrinary symptomsDiseaseNon-motor symptomlcsh:RC346-429SCOPA-AUT03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesInternal medicinemedicineHumansNeurochemistryStage (cooking)lcsh:Neurology. Diseases of the nervous systemAgedbusiness.industryAUTonomic SCale for outcomes in Parkinson’s diseaseParkinson DiseaseGeneral MedicineMiddle AgedUrinary functionmedicine.diseaseAutonomic Nervous System DiseasesQuality of LifeParkinson’s diseaseFemaleSettore MED/26 - NeurologiaNeurology (clinical)Neurosurgerybusiness030217 neurology & neurosurgeryBMC Neurology
researchProduct

Stone-Free Rate after Treating Kidney Stones Exceeding 10 mm via Flexible Ureteroscopy: Can Endoscopic Assessment Replace Low-Dose Computed Tomograph…

2019

<b><i>Introduction:</i></b> It is unclear whether endoscopic assessment of the stone-free rate after flexible ureteroscopy (fURS) is as effective as assessment with low-dose computed tomography (CT) scan. <b><i>Methods:</i></b> Prospective documentation of patients with kidney stones > 10 mm diameter from 2 different centers (Freiburg, Regensburg), who underwent fURS and were declared to be endoscopically completely stone-free. Low-dose CT control performed 4–8 weeks postoperatively. <b><i>Results/Conclusion:</i></b> Thirty-eight patients were treated between October 2015 and August 2016 (12 F, 26 M). Average a…

AdultMaleUrologyStone freemedicine.medical_treatment030232 urology & nephrologyComputed tomographyFlexible ureteroscopyLithotripsyRadiation Dosage03 medical and health sciencesKidney CalculiYoung Adult0302 clinical medicinemedicineUreteroscopyHumansUreteroscopyProspective StudiesAged2. Zero hungerAged 80 and overmedicine.diagnostic_testbusiness.industryLow doseRemission InductionEquipment DesignMiddle Agedmedicine.disease3. Good healthTreatment Outcome030220 oncology & carcinogenesisUreteroscopesKidney stonesFemaleStone removalbusinessNuclear medicineTomography X-Ray ComputedUrologia internationalis
researchProduct

Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-contro…

2019

Introduction Non-invasive vagus nerve stimulation (nVNS; gammaCore®) has the potential to prevent migraine days in patients with migraine on the basis of mechanistic rationale and pilot clinical data. Methods This multicentre study included a 4-week run-in period, a 12-week double-blind period of randomised treatment with nVNS or sham, and a 24-week open-label period of nVNS. Patients were to administer two 120-second stimulations bilaterally to the neck three times daily (6–8 hours apart). Results Of 477 enrolled patients, 332 comprised the intent-to-treat (ITT) population. Mean reductions in migraine days per month (primary outcome) were 2.26 for nVNS (n = 165; baseline, 7.9 days) and 1.8…

AdultMaleVagus Nerve StimulationMigraine DisordersMigraine prophylaxismedicine.medical_treatmentMedizinlaw.inventionDouble blindvagal activation03 medical and health sciences0302 clinical medicineDouble-Blind MethodEpisodic migraineRandomized controlled triallawHumanspreventive therapyMedicineIn patient030304 developmental biologymigraine prophylaxis0303 health sciencesNeuromodulationbusiness.industryNon invasiveNon-pharmacologic treatmentOriginal ArticlesGeneral MedicineMiddle Agedmedicine.diseaseNeuromodulation (medicine)3. Good healthTreatment OutcomeMigrainenon-pharmacologic treatmentAnesthesiaVagal activationFemaleNeurology (clinical)Preventive therapybusinessRCT030217 neurology & neurosurgeryVagus nerve stimulationCephalalgia
researchProduct

Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan

2007

Objective: We designed this trial to investigate if modifications in levels of circulating vascular endothelial growth factor (VEGF) may be related to clinical response and outcome in advanced colorectal cancer patients during treatment with a weekly combination of cetuximab plus irinotecan. Methods: A total of 45 heavily pretreated metastatic colorectal cancer patients were prospectively evaluated for circulating levels of VEGF during the treatment with cetuximab plus weekly irinotecan. VEGF circulating levels were assessed at the following time points: just before and at 1, 21, 50 and 92 days after the start of cetuximab plus irinotecan treatment. Results: Basal VEGF median levels were s…

AdultMaleVascular Endothelial Growth Factor AOncologymedicine.medical_specialtyAngiogenesisColorectal cancerCetuximabAntibodies Monoclonal HumanizedIrinotecanangiogenesiscetuximabcolorectal canceririnotecansurvivalvascular endothelial growth factorBasal (phylogenetics)chemistry.chemical_compoundInternal medicineAntineoplastic Combined Chemotherapy ProtocolsBiomarkers TumorGeneticsmedicineHumansProspective StudiesProspective cohort studyAgedPharmacologyCetuximabbusiness.industryAntibodies MonoclonalMiddle Agedmedicine.diseaseSurvival RateClinical trialVascular endothelial growth factorIrinotecanTreatment OutcomechemistryDisease ProgressionMolecular MedicineCamptothecinFemaleColorectal Neoplasmsbusinessmedicine.drugPharmacogenomics
researchProduct

Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients

2006

INTRODUCTION Angiogenesis has been correlated with increased invasion and metastases in a variety of human neoplasms. Inadequate inhibition of the growth of tumor microvessels by anticancer agents may result in treatment failure, rated clinically as progressive or stable disease. We designed this trial to investigate the modification of the vascular endothelial growth factor (VEGF) and interferon-gamma (IFN-gamma) in advanced colorectal cancer patients during treatment with a weekly combination of cetuximab plus irinotecan. MATERIALS AND METHODS Forty-five metastatic colorectal cancer patients were prospectively evaluated for circulating levels of VEGF and IFN-gamma during the treatment wit…

AdultMaleVascular Endothelial Growth Factor Amedicine.medical_specialtyAngiogenesisColorectal cancerCetuximabAntibodies Monoclonal HumanizedIrinotecanGastroenterologyNeovascularizationInterferon-gammaBasal (phylogenetics)chemistry.chemical_compoundangiogenesis cetuximab colorectal cancer irinotecanInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProspective StudiesProspective cohort studyAgedNeovascularization PathologicCetuximabbusiness.industryAntibodies MonoclonalHematologyMiddle Agedmedicine.diseaseVascular endothelial growth factorIrinotecanTreatment OutcomeEndocrinologyOncologychemistryCamptothecinFemalemedicine.symptomColorectal Neoplasmsbusinessmedicine.drug
researchProduct